Richard A. Heyman, Director: Enliven Therapeutics ELVN Sell · Filed 01/22

Trade details

Type: Insider sale
Amount: $19,357.28
Shares · price: 718 sh · $26.96 a share
Held after: 23,877 sh
Stock: Enliven Therapeutics ELVN
Person: Richard A. HeymanDirector
Trade date: 26/01/20
Filed: 26/01/22
Days to filing: 2 days

Sold 2.9% of holdings

Share of holding sold: 2.9%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/21~02/19

Richard A. Heyman's recent trades

Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$109.1K
8,100 sh
$109.1K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$102.4K
7,600 sh
$102.4K
Filed 10/01
Traded 10/01
Richard A. HeymanDirector
Planned saleEnliven Therapeutics
Planned sale
Enliven Therapeutics
ELVN
$2.3M
38,000 sh
$2.3M
Filed 09/04
Traded 09/04
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$84K
7,000 sh
$84K
Filed 07/06
Traded 07/06
Richard A. HeymanDirector
Planned sale10b5-1 planOric Pharmaceuticals
Planned sale10b5-1 plan
Oric Pharmaceuticals
ORIC
$76.8K
6,400 sh
$76.8K
Filed 07/06
Traded 07/06

Richard A. Heyman, Director — sold $19.4K of Enliven Therapeutics ELVN · 2.9% of holdings · 10b5-1 plan | Whalegun